Clinical Trial Update: Etanercept Treatment in the Early Course of Polymyalgia Rheumatica [Phase 3]

View source ↗

Summary

This clinical trial update covers a Phase 3 study evaluating etanercept for early treatment of polymyalgia rheumatica; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymyalgia Rheumatica

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Bispebjerg Hospital | Conditions: Polymyalgia Rheumatica | Phase 3 | Status: COMPLETED